Haynes BP - Search Results

1

The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistance.

Johnston SR, Riddler S, Haynes BP, A'Hern R, Smith IE, Jarman M, Dowsett M. Johnston SR, et al. Among authors: haynes bp. Br J Cancer. 1997;75(6):804-9. doi: 10.1038/bjc.1997.144. Br J Cancer. 1997. PMID: 9062399 Free PMC article.

2

Idoxifene: report of a phase I study in patients with metastatic breast cancer.

Coombes RC, Haynes BP, Dowsett M, Quigley M, English J, Judson IR, Griggs LJ, Potter GA, McCague R, Jarman M. Coombes RC, et al. Among authors: haynes bp. Cancer Res. 1995 Mar 1;55(5):1070-4. Cancer Res. 1995. PMID: 7866990 Clinical Trial.

3

Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration.

Johnston SR, Haynes BP, Smith IE, Jarman M, Sacks NP, Ebbs SR, Dowsett M. Johnston SR, et al. Among authors: haynes bp. Lancet. 1993 Dec 18-25;342(8886-8887):1521-2. doi: 10.1016/s0140-6736(05)80088-1. Lancet. 1993. PMID: 7902904

4

Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer.

Johnston SR, Haynes BP, Sacks NP, McKinna JA, Griggs LJ, Jarman M, Baum M, Smith IE, Dowsett M. Johnston SR, et al. Among authors: haynes bp. Breast Cancer Res Treat. 1993 Dec;28(3):241-50. doi: 10.1007/BF00666585. Breast Cancer Res Treat. 1993. PMID: 8018953 Clinical Trial.

5

Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.

Johnston SR, Boeddinghaus IM, Riddler S, Haynes BP, Hardcastle IR, Rowlands M, Grimshaw R, Jarman M, Dowsett M. Johnston SR, et al. Among authors: haynes bp. Cancer Res. 1999 Aug 1;59(15):3646-51. Cancer Res. 1999. PMID: 10446976

6

A cancer research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen.

Johnston SR, Gumbrell LA, Evans TR, Coleman RE, Smith IE, Twelves CJ, Soukop M, Rea DW, Earl HM, Howell A, Jones A, Canney P, Powles TJ, Haynes BP, Nutley B, Grimshaw R, Jarman M, Halbert GW, Brampton M, Haviland J, Dowsett M, Coombes RC; Cancer Research UK Phase I/II Committee. Johnston SR, et al. Among authors: haynes bp. Cancer Chemother Pharmacol. 2004 Apr;53(4):341-8. doi: 10.1007/s00280-003-0733-6. Epub 2004 Jan 13. Cancer Chemother Pharmacol. 2004. PMID: 14722733 Clinical Trial.

7

The influence of CGS 16949A on peripheral aromatisation in breast cancer patients.

Lønning PE, Jacobs S, Jones A, Haynes B, Powles T, Dowsett M. Lønning PE, et al. Br J Cancer. 1991 May;63(5):789-93. doi: 10.1038/bjc.1991.175. Br J Cancer. 1991. PMID: 1828173 Free PMC article.

8

Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients.

Dowsett M, MacNeill F, Mehta A, Newton C, Haynes B, Jones A, Jarman M, Lonning P, Powles TJ, Coombes RC. Dowsett M, et al. Br J Cancer. 1991 Nov;64(5):887-94. doi: 10.1038/bjc.1991.420. Br J Cancer. 1991. PMID: 1931611 Free PMC article. Clinical Trial.

9

Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors.

Lønning PE, Haynes BP, Dowsett M. Lønning PE, et al. Among authors: haynes bp. Eur J Cancer. 2014 Apr;50(6):1055-64. doi: 10.1016/j.ejca.2014.01.007. Epub 2014 Feb 4. Eur J Cancer. 2014. PMID: 24507547 Free article.

10

Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039).

Leary A, Evans A, Johnston SR, A'Hern R, Bliss JM, Sahoo R, Detre S, Haynes BP, Hills M, Harper-Wynne C, Bundred N, Coombes G, Smith I, Dowsett M. Leary A, et al. Among authors: haynes bp. Clin Cancer Res. 2015 Jul 1;21(13):2932-40. doi: 10.1158/1078-0432.CCR-14-1428. Epub 2014 Nov 14. Clin Cancer Res. 2015. PMID: 25398453 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters